Omada Health adds Sachin Jain, M.D., MBA, Julie Klapstein and Adam Stavisky to Board of Directors.

SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, the virtual-first healthcare provider, recently published its 28th peer-reviewed study demonstrating the long-term outcomes of utilizing a behavior change program for members with type 2 diabetes. The study, published in The Science of Diabetes Self-Management and Care, is the latest to demonstrate the benefits of Omada’s clinically rigorous approach to behavior change. The results come on the heels of the company’s Insights Lab expansion, which established the ANSWERS initiative to focus on insights derived from combining GLP-1s with a proven behavior change approach. Omada Health offers personalized diabetes management support combining relationship-building, behavior change techniques, diabetes education, and lifestyle modification. Researchers analyzed data from more than one thousand commercially insured members with type 2 diabetes who were enrolled between January 1, 2019, and January 31, 2022, in Omada’s virtual care solution. Within this group, changes in A1C levels and weight were examined over 12 months

SAN FRANCISCO--(BUSINESS WIRE)--Omada Health, a virtual-first healthcare provider, announces its evidence-based behavior change program as one of the lifestyle support programs through EncircleRx, an Express Scripts by Evernorth solution, to help employers and health plans manage cardiodiabesity (obesity, diabetes and cardiovascular disease). The Omada program is designed to help bolster the weight loss of EncircleRx members using GLP-1 medications for weight management. With forecasted use of weight management drugs increasing to approximately nine percent of the U.S. population by 2030, Omada believes it is important to help members adopt behaviors that can improve long-term weight health before, during, and after GLP-1 use. The Omada program is designed to support members at scale in maintaining weight loss through lifestyle modifications delivered by proactive data-empowered care teams and connected devices. In the first output from the new ANSWERS Initiative, Omada partnered with Evernorth to demonstrate the real-world impact of GLP-1s alongside behavior change programs and how this collaboration can improve outcomes